GIA
BIIB icon

GHP Investment Advisors’s Biogen BIIB Stock Holding History

GHP Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.56K Hold
35
– – ﹤0.01% 843
2026
Q1 		$6.42K Buy
35
+4
+13% +$737 ﹤0.01% 866
2025
Q4 		$5.46K Hold
31
– – ﹤0.01% 805
2025
Q3 		$4.34K Sell
31
-51
-62% -$6.89K ﹤0.01% 805
2025
Q2 		$10.3K Sell
82
-5
-6% -$623 ﹤0.01% 712
2025
Q1 		$11.9K Buy
+87
New +$12.4K ﹤0.01% 676
2024
Q4 		– Sell
-638
Closed -$124K – 987
2024
Q3 		$124K Sell
638
-2,110
-77% -$441K 0.01% 420
2024
Q2 		$637K Buy
2,748
+38
+1% +$8.26K 0.03% 286
2024
Q1 		$584K Sell
2,710
-40
-1% -$9.37K 0.03% 298
2023
Q4 		$712K Sell
2,750
-144
-5% -$35.4K 0.04% 283
2023
Q3 		$759K Buy
2,894
+150
+5% +$40.1K 0.05% 275
2023
Q2 		$751K Buy
2,744
+430
+19% +$128K 0.04% 281
2023
Q1 		$643K Buy
2,314
+118
+5% +$32.6K 0.04% 286
2022
Q4 		$608K Sell
2,196
-23
-1% -$6.5K 0.04% 295
2022
Q3 		$592K Sell
2,219
-203
-8% -$43.1K 0.05% 281
2022
Q2 		$494K Sell
2,422
-130
-5% -$26.6K 0.04% 289
2022
Q1 		$537K Buy
2,552
+156
+7% +$33.9K 0.04% 285
2021
Q4 		$575K Sell
2,396
-775
-24% -$199K 0.04% 246
2021
Q3 		$897K Buy
3,171
+268
+9% +$87.8K 0.07% 204
2021
Q2 		$1M Buy
2,903
+32
+1% +$9.69K 0.08% 196
2021
Q1 		$803K Buy
2,871
+620
+28% +$167K 0.07% 202
2020
Q4 		$551K Sell
2,251
-147
-6% -$37.9K 0.05% 214
2020
Q3 		$680K Sell
2,398
-300
-11% -$83.7K 0.08% 200
2020
Q2 		$722K Buy
2,698
+435
+19% +$131K 0.09% 192
2020
Q1 		$716K Buy
2,263
+572
+34% +$174K 0.11% 194
2019
Q4 		$502K Buy
1,691
+305
+22% +$84.6K 0.05% 232
2019
Q3 		$323K Buy
1,386
+42
+3% +$9.78K 0.04% 260
2019
Q2 		$314K Buy
1,344
+101
+8% +$23.3K 0.04% 268
2019
Q1 		$294K Buy
1,243
+60
+5% +$18.9K 0.04% 275
2018
Q4 		$356K Sell
1,183
-110
-9% -$35.1K 0.05% 239
2018
Q3 		$457K Sell
1,293
-100
-7% -$34.4K 0.06% 230
2018
Q2 		$404K Buy
1,393
+200
+17% +$56.2K 0.06% 237
2018
Q1 		$327K Hold
1,193
– – 0.05% 251
2017
Q4 		$380K Buy
1,193
+113
+10% +$36.3K 0.05% 247
2017
Q3 		$338K Hold
1,080
– – 0.05% 254
2017
Q2 		$293K Buy
1,080
+135
+14% +$35.7K 0.05% 267
2017
Q1 		$258K Buy
945
+150
+19% +$42.4K 0.04% 265
2016
Q4 		$225K Buy
795
+105
+15% +$31.1K 0.04% 270
2016
Q3 		$216K Buy
+690
New +$204K 0.04% 267
2016
Q1 		– Sell
-690
Closed -$211K – 285
2015
Q4 		$211K Hold
690
– – 0.05% 268
2015
Q3 		$201K Hold
690
– – 0.05% 264
2015
Q2 		$207K Hold
690
– – 0.05% 270
2015
Q1 		$291K Hold
690
– – 0.08% 225
2014
Q4 		$234K Hold
690
– – 0.06% 242
2014
Q3 		$228K Hold
690
– – 0.07% 237
2014
Q2 		$218K Sell
690
-5
-0.7% -$1.5K 0.06% 252
2014
Q1 		$210K Buy
+695
New +$221K 0.07% 249

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GHP Investment Advisors's BIIB Position: Q2 2026 in Review

GHP Investment Advisors held its Biogen (BIIB) position steady in Q2 2026 at 35 shares worth $7.56K. The position accounts for ﹤0.01% of the portfolio, ranked #843.

GHP Investment Advisors first reported a position in BIIB in Q1 2014 and has held it in 47 quarters since. The position peaked at $1M in Q2 2021. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • GHP Investment Advisors held 35 shares of Biogen worth $7.56K as of Q2 2026.
  • GHP Investment Advisors left its Biogen share count unchanged in Q2 2026.
  • Biogen made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #843 holding.
  • GHP Investment Advisors first reported a position in Biogen in Q1 2014 and has held it in 47 quarters since.
  • GHP Investment Advisors's Biogen position peaked at $1M in Q2 2021.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.